Universal Vision Biotechnology Co (ROCO:3218) Additional Paid-In Capital : NT$382 Mil(As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Universal Vision Biotechnology Co Additional Paid-In Capital?

Universal Vision Biotechnology Co's quarterly additional paid-in capital stayed the same from Jun. 2023 (NT$382 Mil) to Sep. 2023 (NT$382 Mil) and stayed the same from Sep. 2023 (NT$382 Mil) to Dec. 2023 (NT$382 Mil).

Universal Vision Biotechnology Co's annual additional paid-in capital stayed the same from Dec. 2021 (NT$382 Mil) to Dec. 2022 (NT$382 Mil) and stayed the same from Dec. 2022 (NT$382 Mil) to Dec. 2023 (NT$382 Mil).

Universal Vision Biotechnology Co Additional Paid-In Capital Historical Data

The historical data trend for Universal Vision Biotechnology Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Vision Biotechnology Co Additional Paid-In Capital Chart

Universal Vision Biotechnology Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

381.92

Universal Vision Biotechnology Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial															381.92	381.92	381.92	381.92	381.92

Universal Vision Biotechnology Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Universal Vision Biotechnology Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Universal Vision Biotechnology Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Universal Vision Biotechnology Co (ROCO:3218) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Universal Vision Biotechnology Co Ltd (ROCO:3218) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 3-1, Yuanyuan Street, 4th Floor, Nangang District, Taipei, TWN, 115

Website

https://www.uvb.com.tw

Universal Vision Biotechnology Co Ltd provides eye treatment and related medical services in Taiwan. It also provides optical devices, glasses, lens and other vision aid products, optometric services, sales and leasing of medical devices, providing of hospital management and technical consultancy services.

Universal Vision Biotechnology Co (ROCO:3218) Headlines

No Headlines